Neuroendovascular Surgeon
Health First Medical Group
Efficacy and Safety of Very-Low-Dose Cangrelor Following Acute Neuroendovascular Intervention
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure information not submitted.